Market Research Logo

Global PCR Multiplex Assays Market – Industry Trends & Forecast to 2026

Global PCR Multiplex Assays Market – Industry Trends & Forecast to 2026

Short Description
By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Market Definition:
The multiplex assays can be applied for detection of pathogens and causing agents of infectious diseases such as viruses, bacteria and parasites. With the wide application of the PCR multiplex assays in drug discovery, bio marker discovery, clinical research and diagnostic of infectious diseases and genetic disorders in research and development laboratories, leading the manufacturers to advances the multiplex assays by overcoming the challenges of the optimization of PCR multiplexes. The PCR multiplex can be distinguished in single template PCR reaction and multiple template PCR reaction.
The automated PCR system is designed with the advanced technology which can detect multiple targets in single test. Quanterix (U.S.) offers Quanterix SR-Plex benchtop instrument which is designed with automated HD-1 Analyzer which helps in the detection of measurement of biomarkers with extraordinary sensitivity. The instrument utilizes single molecule measurements to evaluate previously undetectable proteins and reduces sample volume.
The simultaneously amplification of the multiple sequences in a single reaction is a cost effective, adequate, rapid and accurate procedure of clinical research laboratories. For the multiplex reaction with PCR primer, is required for successful reaction of multiplex. The PCR multiplex assays are designed for high throughput SNP genotyping, pathogen identification, mutation analysis, gene deletion analysis, linkage analysis, template quantitation, RNA detection and other forensic studies.

Market Segmentation:
Global PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.
• On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.
• On the basis of application, the market is segmented into research & development and clinical diagnostics.
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.

Market Players
The key market players are listed below
• Thermo Fisher Scientific Inc.
• Luminex Corporation
• BD
• QIAGEN
• Agilent Technologies Inc.
• Meso Scale Diagnostics, LLC
• Randox Laboratories Ltd.
• Bio-Techne, Seegene Inc.
• Olink
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Abcam Plc
• Quanterix
• Sysmex Corporation
• Siemens
• F. Hoffmann-La Roche Ltd
• Hologic Inc.
• Diasorin
• Abbott
• Quest Diagnostics Incorporated
• PerkinElmer Inc.
• Eurofins Scientific
• Agena Bioscience, Inc.

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Pcr Multiplex Assays Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Global Pcr Multiplex Assays Market: Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Dbmr Market Position Grid
2.8 Market Application Coverage Grid
2.9 Dbmr Vendor Share Analysis
2.10 Multivariate Modeling
2.11 Products Lifeline Curve
2.12 Secondary Sources
2.13 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Technological Advancements Of Pcr Multiplex Assays
3.1.2 Introduction Of Novel Automated Systems
3.1.3 Growing Research And Development For Drug Discovery
3.1.4 Use Of Multiplex Assays In Companion Diagnostics
3.2 Restraints
3.2.1 High Cost Of The Multiplex Assays
3.2.2 Stringent Regulations And Standards
3.3 Opportunities
3.3.1 Growing Validation Of Biomarkers In Molecular And Protein Diagnostics
3.3.2 Business Expansion For Development Of Pcr Multiplex Assays
3.4 Challenge
3.4.1 Lack Of Proficient Labour To Handle Advanced Procedures
4 Executive Summary
5 Premium Insights
6 Global Pcr Multiplex Assays Market, By Products & Services
6.1 Overview
6.2 Reagents & Consumables
6.3 Instruments & Accessories
6.4 Software And Services
7 Global Pcr Multiplex Assays Market, By Application
7.1 Overview
7.2 Clinical Diagnostics
7.2.1 Cancer
7.2.2 Cardiovascular Diseases
7.2.3 Respiratory Diseases
7.2.4 Metabolism & Endocrinology Disorders
7.2.5 Nervous System Disorders
7.2.6 Autoimmune Diseases
7.2.7 Allergies
7.2.8 Others
7.3 Research & Development
7.3.1 Drug Discovery & Development
7.3.2 Biomarker Discovery & Validation
8 Global Pcr Multiplex Assays Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Clinical Laboratories
8.4 Pharmaceutical & Biotechnology Companies
8.5 Research Institutes
8.6 Others
9 Global Pcr Multiplex Assays Market, By Geography
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Switzerland
9.3.7 Netherlands
9.3.8 Belgium
9.3.9 Austria
9.3.10 Ireland
9.3.11 Rest Of Europe
9.4 Asia-pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Singapore
9.4.7 Malaysia
9.4.8 Indonesia
9.4.9 Thailand
9.4.10 Philippines
9.4.11 Rest Of Asia-pacific
9.5 South America
9.5.1 Brazil
9.5.2 Rest Of South America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Rest Of Middle East & Africa
10 Global Pcr Multiplex Assays Market, Company Landscape
10.1 Company Share Analysis: Global
10.2 Company Share Analysis: North America
10.3 Company Share Analysis: Europe
10.4 Company Share Analysis: Asia-pacific
11 Swot Analysis
11.1 Strength: - Significant Increasing Shares In Market Focused Segment
11.2 Strength: - Strong Global Presence And Market Share
11.3 Weakness: - Product Recall
11.4 Opportunity: - Strategic Investments
11.5 Threat: - Stiff Competition
12 Company Profiles
12.1 F. Hoffmann-la Roche Ltd.
12.1.1 Company Snapshot
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Hol0gic Inc
12.2.1 Company Snapshot
12.2.2 Revenue Analysis
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Luminex Corporation.
12.3.1 Company Snapshot
12.3.2 Revenue Analysis
12.3.3 Company Share Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Becton, Dickinson And Company
12.4.1 Company Snapshot
12.4.2 Revenue Analysis
12.4.3 Company Share Analysis
12.4.4 Product Portfolio
12.4.5 Recent Developments
12.5 Abbott
12.5.1 Company Snapshot
12.5.2 Revenue Analysis
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Agena Bioscience, Inc
12.6.1 Company Snapshot
12.6.2 Product Portfolio
12.6.3 Recent Development
12.7 Agilent Technologies, Inc
12.7.1 Company Snapshot
12.7.2 Revenue Analysis
12.7.3 Product Portfolio
12.7.4 Recent Development
12.8 Bio-rad Laboratories, Inc.
12.8.1 Company Snapshot
12.8.2 Revenue Analysis
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Biomérieux Sa
12.9.1 Company Snapshot
12.9.2 Revenue Analysis
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Biotek Instruments, Inc.
12.10.1 Company Snapshot
12.10.2 Product Portfolio
12.10.3 Recent Development
12.11 Diasorin S.P.A
12.11.1 Company Snapshot
12.11.2 Revenue Analysis
12.11.3 Product Portfolio
12.11.4 Recent Development
12.12 Eurofins Scientific
12.12.1 Company Snapshot
12.12.2 Revenue Analysis
12.12.3 Product Portfolio
12.12.4 Recent Development
12.13 Illumina, Inc.
12.13.1 Company Snapshot
12.13.2 Revenue Analysis
12.13.3 Product Portfolio
12.13.4 Recent Development
12.14 Olink
12.14.1 Company Snapshot
12.14.2 Product Portfolio
12.14.3 Recent Development
12.15 Pathonostics B.V.
12.15.1 Company Snapshot
12.15.2 Product Portfolio
12.15.3 Recent Development
12.16 Perkinelmer Inc.
12.16.1 Company Snapshot
12.16.2 Revenue Analysis
12.16.3 Product Portfolio
12.16.4 Recent Development
12.17 Qiagen
12.17.1 Company Snapshot
12.17.2 Revenue Analysis
12.17.3 Product Portfolio
12.17.4 Recent Developments
12.18 Quest Diagnostics Incorporated
12.18.1 Company Snapshot
12.18.2 Revenue Analysis
12.18.3 Product Portfolio
12.18.4 Recent Development
12.19 Randox Laboratories Ltd.
12.19.1 Company Snapshot
12.19.2 Product Portfolio
12.19.3 Recent Development
12.20 Seegene Inc.
12.20.1 Company Snapshot
12.20.2 Revenue Analysis
12.20.3 Product Portfolio
12.20.4 Recent Development
12.21 Siemens
12.21.1 Company Snapshot
12.21.2 Revenue Analysis
12.21.3 Product Portfolio
12.21.4 Recent Developments
12.22 Sysmex Corporation
12.22.1 Company Snapshot
12.22.2 Revenue Analysis
12.22.3 Product Portfolio
12.22.4 Recent Developments
12.23 Thermo Fisher Scientific Inc.
12.23.1 Company Snapshot
12.23.2 Revenue Analysis
12.23.3 Product Portfolio
12.23.4 Recent Development
13 Conclusion
14 Questionnaire
15 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report